Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Establishment of a canine urothelial carcinoma-derived organoid biobank: A platform for comparative and translational research.
PMID 41889014 · PMC13140855 · Clinical and translational medicine · 2026 · 8 claims · 6 setups
Canine urothelial carcinoma closely resembles human muscle-invasive bladder cancer in histopathology, molecular features, biological behavior, metastatic patterns, therapeutic response, and clinical outcome
-
Full-text index only
X-linked cancer-associated polypeptide (XCP) from lncRNA1456 modulates PHF8 histone demethylase activity to regulate the epigenome, gene expression, and cellular pathways in breast cancer.
PMID 41922576 · PMC13099652 · Oncogene · 2026 · 8 claims · 8 setups
lncRNA1456, previously classified as noncoding, encodes a 132 amino acid protein named XCP (X-linked Cancer-associated Polypeptide)
-
Full-text index only
Targeting TPX2-dependent lineage plasticity by CDK4/6 inhibition reverses therapy resistance in neuroendocrine bladder carcinoma.
PMID 41923619 · PMC13130694 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
A 315-gene 'NE-like signature' (NE-like Sig), derived from the WGCNA MEmidnightblue module, marks a lineage-plasticity-associated transcriptional program distinct from canonical NE differentiation.
-
Full-text index only
Single-cell analysis highlights the significance of malignant cell IFN/MHC-II for immunotherapy response in head and neck squamous cell carcinoma.
PMID 41923630 · PMC13130666 · Cell reports. Medicine · 2026 · 8 claims · 4 setups
A malignant cell subset expressing IFN-response and MHC-II genes (IFN/MHC-II) increases in proportion after pembrolizumab treatment and is associated with response
-
Full-text index only
Integrated spatial transcriptomics and pan-cancer XGBoost modeling uncover spatial drivers of immune exclusion and predict immunotherapy response.
PMID 41925746 · PMC13046951 · Cancer immunology, immunotherapy : CII · 2026 · 8 claims · 8 setups
A three-step computational framework (ImmCeRNA) identified 6,070 immune-related ceRNA interactions across 27 cancer types by integrating expression correlation and experimental validation data.
-
Full-text index only
Helicobacter pylori-linked gene CFAP73 rewires epithelial programs and shapes the gastric cancer microenvironment.
PMID 41934579 · PMC13199538 · Discover oncology · 2026 · 8 claims · 8 setups
CFAP73 is progressively downregulated during HP infection and is the top-ranked predictor among nine HP-suppressed genes associated with favorable gastric cancer survival
-
Full-text index only
Targeting KIFC1 to disrupt centrosome clustering and trigger anaphase catastrophe in small-cell lung cancer.
PMID 41948931 · PMC13134724 · JCI insight · 2026 · 8 claims · 8 setups
KIFC1 is overexpressed in SCLC compared with normal tissues and other cancer types
-
Full-text index only
Glioblastoma invasion into different organoid hosts reveals cell-intrinsic and proliferative migratory programs.
PMID 41959666 · PMC13059114 · iScience · 2026 · 8 claims · 8 setups
GB cells invade both neural and endodermal organoid hosts (lineage-independent), whereas non-malignant neural progenitor cells show markedly reduced infiltration
-
Full-text index only
Dissecting origin factors of lymph node metastasis in non-small cell lung cancer via multimodal omics.
PMID 41975179 · PMC13250061 · Nature communications · 2026 · 8 claims · 8 setups
Epithelial cells in mLNs and matched mLN+ primary tumors (mLN+PTs) show enhanced cancer stemness (higher CytoTRACE scores) compared to mLN-negative and normal samples.
-
Full-text index only
Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.
PMID 41986344 · PMC13083995 · Nature communications · 2026 · 8 claims · 8 setups
BRAFi (vemurafenib) treatment drives BRAF-mutant melanoma cells through a reversible dedifferentiation transition from a melanocytic state through a neural crest-like state to a drug-tolerant mesenchymal state
-
Full-text index only
A transcriptomic-based model associated with PARP inhibitor sensitivity and immunogenic signatures in ovarian cancer.
PMID 42014663 · PMC13230468 · Discover oncology · 2026 · 8 claims · 8 setups
A 23-gene PARPi-sensor transcriptomic model stratifies ovarian cancer patients into high- and low-risk groups with significantly different overall survival, validated in TCGA and ICGC cohorts
-
Full-text index only
Resolving sensitivity, specificity and signal contamination in Xenium spatial transcriptomics.
PMID 42062553 · PMC13259927 · Nature methods · 2026 · 8 claims · 6 setups
Xenium data show strong consistency across patients and technical replicates, with little technical variation between platforms
-
Full-text index only
Development of predictive models for the prognosis of triple-negative breast cancer using multiple transcriptomic analyses.
PMID 42081506 · PMC13138617 · PloS one · 2026 · 7 claims · 6 setups
Developed TNBC prognosis predictive models (CoxPH-based) achieving predictive performance exceeding 0.94 AUC, surpassing all prior published TNBC prognosis models (max prior AUC ~0.85)
-
Full-text index only
Decoding drug-responsive cell subpopulations in triple-negative breast cancer using single-cell multiomics.
PMID 42088352 · PMC13138057 · iScience · 2026 · 8 claims · 8 setups
A multimodal framework bridging bulk and single-cell transcriptomics data identifies drug-responsive cell subpopulations in TNBC
-
Full-text index only
A statistical change point model approach for the detection of DNA copy number variations in array CGH data.
PMID 19875853 · PMC4154476 · IEEE/ACM transactions on computational biology and bioinformatics · 2009 · 7 claims · 4 setups
A novel mean and variance change point model (MVCM) is proposed to detect CNVs/breakpoints in aCGH data.
-
Has reproduction · 62
scATD: a high-throughput and interpretable framework for single-cell cancer drug resistance prediction and biomarker identification.
PMID 40501071 · PMC12159290 · Briefings in bioinformatics · 2025 · 8 claims · 6 setups
scATD enables high-throughput single-cell drug sensitivity prediction for new patients without model parameter retraining via bidirectional Bi-AdaIN style transfer
-
Full-text index only
SpaPheno: linking spatial transcriptomics to clinical phenotypes with interpretable machine learning.
PMID 41975540 · PMC13185361 · Genome medicine · 2026 · 8 claims · 8 setups
SpaPheno integrates spatial transcriptomics with clinically annotated bulk RNA-seq to identify spatially resolved biomarkers predictive of patient outcomes including survival, tumor stage, and immunotherapy response
-
Full-text index only
Frequent and multiple mutations at minisatellite loci in sporadic human colorectal and gastric cancers--possible mechanistic differences from microsatellite instability in cancer cells.
PMID 11985787 · PMC5927018 · Japanese journal of cancer research : Gann · 2002 · 6 claims · 3 setups
MN mutations occur significantly more frequently in sporadic colorectal cancer (56%) than in gastric cancer (25%)
-
Full-text index only
Have microarrays failed to deliver for developmental biology?
PMID 12225576 · PMC139405 · Genome biology · 2002 · 8 claims · 8 setups
Despite predictions that microarrays would transform biology, very few published developmental biology microarray studies have generated novel insights.
-
Full-text index only
DLX2 marks an immunosuppressive dendritic-cell program that reshapes cytotoxic immunity and marks a tolerogenic microenvironment in lung adenocarcinoma.
PMID 41761000 · PMC13043845 · Discover oncology · 2026 · 8 claims · 8 setups
Neuroactive ligand–receptor signaling is among the most significantly upregulated pathways in LUAD relative to normal lung tissue.